SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-023902
Filing Date
2019-05-06
Accepted
2019-05-06 16:12:49
Documents
53
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv519467_10q.htm 10-Q 358992
2 EXHIBIT 31.1 tv519467_ex31-1.htm EX-31.1 11968
3 EXHIBIT 31.2 tv519467_ex31-2.htm EX-31.2 11480
4 EXHIBIT 32.1 tv519467_ex32-1.htm EX-32.1 4852
  Complete submission text file 0001144204-19-023902.txt   4692376

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT clrb-20190331.xml EX-101.INS 1356911
6 XBRL TAXONOMY EXTENSION SCHEMA clrb-20190331.xsd EX-101.SCH 30971
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clrb-20190331_cal.xml EX-101.CAL 29316
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clrb-20190331_def.xml EX-101.DEF 242706
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clrb-20190331_lab.xml EX-101.LAB 280375
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clrb-20190331_pre.xml EX-101.PRE 280063
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36598 | Film No.: 19799446
SIC: 2834 Pharmaceutical Preparations